/Investor DB

Calculus Capital Ltd. — Full Portfolio

45 tracked investments · listed companies and verified rows first

Laverock Therapeuticslaverocktx.comin✓ verified

Laverock Tx is a biotechnology company working in the gene therapy and gene editing space, with a leadership and advisory team drawn from cell and gene therapy, immunology, and life-science investing backgrounds.

BiotechDeep TechHealthtech

Co-investorsEos AdvisoryFuture Planet CapitalTekfen VenturesUK Innovation & Science Seed Fund

Riff Raff Entertainmentriffraffentertainment.com✓ verified

Riff Raff Entertainment is a filmmaker- and talent-led production company that develops and produces films and television series, including the Netflix series Black Rabbit and the feature film The Order.

Media & Entertainment

Jude Law(Co-founder)Ben Jackson(Co-founder)

Arctic Shoresarcticshores.comin

Arctic Shores provides psychometric testing and recruitment tools designed to reduce hiring bias and support diversity goals for businesses.

AI & Machine LearningHR TechSaaS

Co-investorsBeringeaBeringea ProVen VCTPraetura Ventures

Arecorarecor.cominSep 2018

AreCor develops proprietary pharmaceutical products for diabetes, obesity, and cardiometabolic diseases using its Arestat technology platform.

BiotechDeep TechHealthtech

Sarah Howellin

Co-investorsAlbionVCCambridge Capital GroupSeneca Partners

Blu Wirelessbluwireless.comin𝕏May 2019 · $16.6M

Blu Wireless develops millimeter wave radio networking technology for wireless communications.

Deep TechDefense TechHardwareSemiconductorsBristol, GB

Anthony Murray(Chief Executive Officer)inJohnny Bray(Chief Financial Officer)inDave Purle(Chief Operating Officer)Ciara Barron(Director of Marketing)inDarren McNamara(Director of Technology Development)inJonathan Rogers(Director of Systems and Platforms)in

Co-investorsMaven Capital PartnersCambridge Angels groupPerscitus LLPSalica InvestmentsARMGuinness Asset Management+2 more

Blu Wireless Technologybluwirelesstechnology.comJun 2017

Bristol-based developer of mmWave wireless communication systems for defence, high-speed rail and other mobility markets.

Co-investorsACF InvestorsGuinness VenturesPerscitus LLPARMCalculusWren Capital

Edifyin𝕏

AI-powered operations platform built for quick service restaurants and hospitality chains.

Ensilitechensilitech.comin

EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration.

BiotechCleantechDeep TechHealthtechMedical Devices

Asel Sartbaeva(Co-Founder & CEO)inMatt Slade(Co-Founder & Chief of Staff)inStephen Wells(Co-Founder & Advisor)Aswin Doekhie(Co-Founder & CTO)inSabine Ficek(CFO)inSimon Bennett(Chief Commercial Officer)

Co-investorsElbow Beach CapitalEos AdvisoryEmpirical VenturesHERmesa

Essentia Analyticsessentia-analytics.comin𝕏

Essentia Analytics offers an analytics and coaching service that identifies behavioral patterns in portfolio managers' investment decisions and delivers tailored nudges and coaching to reduce cognitive bias and improve investment performance.

AI & Machine LearningData & InfrastructureFintechSaaS

Clare Flynn Levy(CEO)inCharley Ellis(Non-Executive Director)

Co-investorsSalica Investments

Inviziusinvizius.cominMay 2021

Invizius develops therapeutics targeting the complement system to treat kidney disease and other disorders driven by uncontrolled immune activation.

BiotechDeep TechHealthtechMedical DevicesGlasgow, GB

Dr Magnus Nicolsonin

Co-investorsCalculusMercia VenturesOld College CapitalScottish EnterpriseScottish Investment BankSyensqo Ventures

Maven Screen Mediamavenscreenmedia.com

Maven Screen Media is an independent production company that develops and produces multi-platform film and television content with a focus on increasing representation for women in front of and behind the camera.

Creator EconomyMedia & Entertainment

Celine RattrayTrudie Stylerin

Co-investorsAdeline

Optalitixoptalitix.comin

Optalitix provides an enterprise platform that consolidates pricing and underwriting workflows, enabling organizations to modernize their pricing models without disruption through incremental cloud migration and governance.

AI & Machine LearningCloud ComputingEnterprise SoftwareFintechInsurTechSaaSLondon, GB

Co-investors24 HaymarketUnited Trust Bank

Oxford BioTherapeuticsoxfordbiotherapeutics.com

Oxford BioTherapeutics is a clinical-stage oncology company developing antibody-based therapies for cancer treatment.

BiotechHealthtechMedical DevicesOxford, GB

Co-investorsOxfordPercipient CapitalPerscitus LLP

Resurrect Bioresurrect.bioinFeb 2026 · $8.1M

Resurrect Bio develops more durable crop disease resistance by engineering plant immune receptors, combining plant molecular immunology, computational biology, AI, and high-throughput screening.

AgTechAI & Machine LearningBiotechLondon, GB

Cian Duggan(CEO & Co-Founder)inTolga Bozkurt(Co-Founder)inSophien Kamoun(Co-Founder)in

Co-investorsFuture Planet CapitalGrowth Science VenturesPymwymicSynBioVenUK Innovation & Science Seed FundAgFunder

Rotageekrotageek.comin𝕏Jun 2022

Rotageek provides workforce management and scheduling software for rota planning, including demand forecasting, labour modelling, auto-scheduling, time and attendance tracking, and leave management.

AI & Machine LearningFuture of WorkHR TechRetail TechSaaS

Chris McCullough(Co-founder)inRoy Pounder(Co-founder)inNick Mann(Co-founder)in

Co-investorsVenture FoundersVolution VenturesCalculusGresham HouseGresham House VenturesMobeus Equity Partners+2 more

Smartr365smartr365.comin

An end-to-end mortgage and protection platform that automates the mortgage process and integrates brokers, estate agents, homebuyers and lenders.

Conor Murphy(Founder)in

Co-investorsPembroke VCTFig VCLegal & General

Spectral MDspectralmd.comSep 2018

AI medical diagnostics company whose DeepView imaging platform predicts whether burns and other wounds will heal.

BiotechDallas, US

J. Michael DiMaio(Executive Officer, Director)John H, Stevens(Director)Erich Spangenberg(Director)

Tagomicstagomics.comFeb 2024

Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB

Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)

Co-investorsIllumina VenturesIQ CapitalStart CodonCalculusIllumina InnovationInnovate UK+3 more

Trogenixtrogenixbio.cominOct 2025

Trogenix develops precision gene therapies for cancer using its Odysseus platform and Synthetic Super-Enhancer (SSE) technology, engineered DNA elements activated only in diseased cell states to selectively target and kill tumour cells while activating the immune system.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB

Ken Macnamarain

Co-investorsACADEMY INVESTORAIN VenturesIQ CapitalLongeVCOld College Capital4BIO Capital

Wazokuwazoku.comin𝕏Sep 2022

Wazoku is a London-based innovation management company combining an AI platform with the Innocentive open-innovation solver marketplace.

London, GB

Simon Hill(CEO)inRosemarie Diegnan(Co-founder, Chief Product & Customer Officer)in

Co-investorsCambridge Angels groupOctopus VenturesSaaS Capital

Weedingtechweedingtech.com

Supplies machines and supplies that kill weeds without using herbicides.

Co-investorsBoundary CapitalCalculus

Wonderhood Studioswonderhoodstudios.com

Wonderhood Studios is a creative studio that produces content and campaigns for brands and broadcasters.

Media & Entertainment

Co-investorsAnjost

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Axol Bioscience Censo BiotechnologiesBooked ItBrouhaha EntertainmentC4X DiscoveryCenso Biotechnologies (Axol Bioscience)EconsultFiscal TechnologiesGratefulHinterviewHome Team ContentIpvMip DiagnosticsMoNotifyOpen Energy MarketQuaiRaindog FilmsRiff RaffScancellTozaroWonderhoodWorkl

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.